Loading organizations...
Loading organizations...
Biotech company developing bispecific antibodies for IBD.
Caldera Therapeutics has raised $37.5M across 1 funding round.
Caldera Therapeutics has raised $37.5M in total across 1 funding round.
Caldera Therapeutics has raised $37.5M in total across 1 funding round.
Caldera Therapeutics's investors include Michelle Doig, Janus Henderson Investors, Wellington Management.
Caldera Therapeutics has raised $37.5M across 1 funding round. Most recently, it raised $37.5M Series A in January 2026.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 14, 2026 | $37.5M Series A | Michelle Doig | Janus Henderson Investors, Wellington Management |